Anzeigenschluss: 05.02.2025
Erscheinungstermin: 28.02.2025
Fortbildung
- CME: Tabakentwöhnung – so schaffen es Ihre Patienten
- Fortbildung: Gesundheitliche Risiken durch Cannabiskonsum: Kiffen, Vapen, Dabben – die Lunge leidet immer
- Fortbildung: COPD und Sport
Journal Club
- YouTube-videos for patient education in lymphangioleiomyomatosis?
- Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trial
- Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
- Sorin et al (2024) Neoadjuvant chemoimmunotherapy for NSCLC (Non Small Cell Lung Cancer). A systematic review and meta-analysis
- Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
- Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study
- Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in COPD: A Cross-Sectional Observational Study
- Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
- Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial
- Prognostic impact of targetable driver alterations in resected early-stage lung cancer
*Die Redaktion behält sich aktuelle Änderungen vor.